Photronics guided Q2 non-GAAP EPS of $0.49 to $0.55 on February 27, 2026; actual non-GAAP EPS came in at $0.42 per diluted share -- and cost pressures that drove the miss were absent from the Company's forward outlook.

Shareholders who held Photronics (NASDAQ: PLAB) stock lost more than 30% of their investment today after the Company reported fiscal Q2 results that fell below its own guidance. Those who purchased PLAB shares and suffered a loss are encouraged to submit their information to discuss their legal rights. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

On February 27, 2026, President & CFO Eric Rivera guided investors to expect fiscal Q2 non-GAAP diluted EPS of $0.49 to $0.55 and operating margins of 22% to 24%. Rivera acknowledged that the Company operates with only 1-to-3 weeks of backlog visibility. The guidance did not quantify known cost headwinds, including accelerated depreciation tied to end-of-life tool purchases and rising capital expenditures. CEO George Macricostas told investors the Company was "optimistic" that "high-end strength will continue" to offset seasonal effects from Chinese New Year.

When Q2 results arrived on May 28, 2026, non-GAAP diluted EPS was $0.42 -- well below the low end of the projected range. Revenue of $209.9 million landed beneath the Company's prior quarterly expectations for $212 to $220 million. PLAB shares fell approximately 30% in a single session.

PLAB investors who lost money can click here to get additional information. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

Levi & Korsinsky, LLP -- Top 50 securities litigation firm (ISS, seven consecutive years). Over 70 professionals. Hundreds of millions recovered.

Frequently Asked Questions About the PLAB Investigation

Q: What is the PLAB securities fraud investigation about? A: A securities fraud investigation has been initiated concerning Photronics (NASDAQ: PLAB) regarding potentially materially false and misleading statements. Shares fell approximately 30% after the Company reported Q2 results below its own guidance, causing significant losses for shareholders.

Q: Who is eligible to participate in the PLAB investigation? A: Investors who purchased PLAB stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.

Q: What do PLAB investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at jlevi@levikorsinsky.com or (212) 363-7500. No immediate action is required to remain eligible to participate in the investigation.

Q: What happens after I contact Levi & Korsinsky? A: An attorney will review your trading history at no cost and provide an initial assessment of your potential recovery.

Q: What if I already sold my PLAB shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought PLAB and sold at a loss may still participate in the investigation.

Q: What does it cost me to participate? A: Nothing. Securities investigations and any resulting actions are handled on a pure contingency basis. No upfront fees, no retainer, no out-of-pocket costs.

Q: What if I live outside the United States? A: U.S. securities fraud investigations generally cover purchases on U.S. exchanges regardless of the investor's country of residence.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260601498080/en/